Qiming et al to Boost Cancer Drug Development
12 Jan 2026
US$ 20.00
Qiming Venture Partners (Qiming) has co-led the US$70 m series C1 financing round of Oricell Therapeutics Holdings ......
Related Publications
Subscribers’ Weekly for the week ending 3 Apri 2026...
Listen to Subscribers' Weekly 03 Apr 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.